![]() |
|
|
S Greenberg, C McGowan, J Xie and WR Summer
Department of Medicine, Physiology and Pharmacology, LSU Medical Center, New Orleans.
Furosemide and morphine reduce pulmonary edema associated with congestive heart failure. It is uncertain whether furosemide or morphine are direct-acting relaxants of arterial and venous smooth muscle. The authors compared the effect of furosemide and morphine on isolated rings of canine pulmonary artery (PA) and vein (PV) and mesenteric, splenic and anterior tibial arteries and their corresponding veins precontracted with norepinephrine or (15S)-hydroxy- 11 alpha, 9 alpha-(epoxymethano)prosta-5Z,13E-dienoic acid. Furosemide (10-300 microM) selectively relaxed veins by an endothelium-independent mechanism, with its greatest efficacy on the PV. Morphine (10-1000 microM) relaxed both arteries and veins. The mechanism of relaxation by furosemide and morphine was examined in the PV and PA. Morphine-induced relaxation of the PV and PA was dependent on prostanoid release from endothelium and smooth muscle because it was attenuated in endothelium- rubbed and ibuprofen-treated PV and PA but not in blood vessels treated with inhibitors of nitric oxide system/cyclic GMP system (I-NG- nitroarginine and methylene blue). Furosemide-mediated relaxation of the PV was refractory to each of these interventions. Similarly, furosemide- and morphine-induced relaxation of the PV were unaffected by 4-aminopyridine, tetraethylammonium, glibenclamide, dendrodotoxin and apamin and, thereby, were independent of an action on K+ channels. Reduction of extracellular K+ or Cl- attenuated furosemide-mediated relaxation of, and inhibition of 86Rb+ uptake by, PV even in the presence of ouabain. It was concluded that furosemide relaxes veins by an effect on Na+/K+/Cl- cotransport or chloride-mediated refilling of intracellular calcium stores.
This article has been cited by other articles:
![]() |
P. Garg, C. F. Martin, S. C. Elms, F. J. Gordon, S. M. Wall, C. J. Garland, R. L. Sutliff, and W. C. O'Neill Effect of the Na-K-2Cl cotransporter NKCC1 on systemic blood pressure and smooth muscle tone Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2100 - H2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Uemura, A. Kamiya, I. Hidaka, T. Kawada, S. Shimizu, T. Shishido, M. Yoshizawa, M. Sugimachi, and K. Sunagawa Automated drug delivery system to control systemic arterial pressure, cardiac output, and left heart filling pressure in acute decompensated heart failure J Appl Physiol, April 1, 2006; 100(4): 1278 - 1286. [Abstract] [Full Text] [PDF] |
||||
![]() |
S U Shah, S Anjum, and W A Littler Use of diuretics in cardiovascular disease: (2) hypertension Postgrad. Med. J., May 1, 2004; 80(943): 271 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jiang, F. Akar, S. L. Cobbs, K. Lomashvilli, R. Lakkis, F. J. Gordon, R. L. Sutliff, and W. C. O'Neill Blood pressure regulates the activity and function of the Na-K-2Cl cotransporter in vascular smooth muscle Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1552 - H1557. [Abstract] [Full Text] [PDF] |
||||
![]() |
S U Shah, S Anjum, and W A Littler Use of diuretics in cardiovascular diseases: (1) heart failure Postgrad. Med. J., April 1, 2004; 80(942): 201 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Meyer, M. Flagella, R. L. Sutliff, J. N. Lorenz, M. L. Nieman, C. S. Weber, R. J. Paul, and G. E. Shull Decreased blood pressure and vascular smooth muscle tone in mice lacking basolateral Na+-K+-2Cl- cotransporter Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1846 - H1855. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Corboz, S. T. Ballard, H. Gao, J. N. Benoit, S. K. Inglis, and A. E. Taylor Differential effects of furosemide on porcine bronchial arterial and airway smooth muscle J Appl Physiol, October 1, 2000; 89(4): 1360 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Akar, E. Skinner, J. D. Klein, M. Jena, R. J. Paul, and W. C. O'Neill Vasoconstrictors and nitrovasodilators reciprocally regulate the Na+-K+-2Cl- cotransporter in rat aorta Am J Physiol Cell Physiol, June 1, 1999; 276(6): C1383 - C1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pickkers, T. P. J. Dormans, F. G. M. Russel, A. D. Hughes, T. Thien, N. Schaper, and P. Smits Direct Vascular Effects of Furosemide in Humans Circulation, September 16, 1997; 96(6): 1847 - 1852. [Abstract] [Full Text] |
||||
![]() |
K. Haugan, M. Shalmi, J. S. Petersen, N. Marcussen, J. Spannow, and S. Christensen Effects of Renal Papillary-Medullary Lesion on the Antihypertensive Effect of Furosemide and Development of Salt-Sensitive Hypertension in Dahl-S Rats J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1415 - 1422. [Abstract] [Full Text] |
||||